- Home
- LFCR
LFCR
Lifecore Biomedical Inc.
as 06-20-2025 4:00pm EST
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | CHASKA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 234.3K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.68 - $7.99 | Next Earning Date: | 04-03-2025 |
| Revenue: | $130,309,000 | Revenue Growth: | 7.23% |
| Revenue Growth (this year): | 1.64% | Revenue Growth (next year): | 2.91% |
Stock Insider Trading Activity of Lifecore Biomedical Inc. (LFCR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| English Aron R. | LFCR | 10% Owner | May 23 '25 | Sell | $6.79 | 1,386,060 | $9,132,503.00 | 414,599 | |
| English Aron R. | LFCR | 10% Owner | May 13 '25 | Sell | $7.00 | 12,334 | $86,352.80 | 414,599 | |
| English Aron R. | LFCR | 10% Owner | May 8 '25 | Sell | $7.01 | 51,496 | $362,019.16 | 414,599 | |
| English Aron R. | LFCR | 10% Owner | May 5 '25 | Sell | $7.05 | 41,091 | $289,869.36 | 414,599 |
Latest Lifecore Biomedical Inc. News
LFCR Breaking Stock News: Dive into LFCR Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer
GlobeNewswire
4 days ago
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
MT Newswires
9 days ago
Lifecore Biomedical Receives Remaining $10 Million for Sale of Isolator Filler Ahead of Schedule
GlobeNewswire
9 days ago
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
Simply Wall St.
23 days ago
Lifecore Biomedical (NASDAQ:LFCR) shareholders have endured a 37% loss from investing in the stock five years ago
GlobeNewswire
25 days ago
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
Insider Monkey
a month ago
What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
MT Newswires
a month ago
William Blair Initiates Coverage on Lifecore Biomedical With Outperform Rating
Compare LFCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFCR Lifecore Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.